Skip Regulates TGF-β1-Induced Extracellular Matrix Degrading Proteases Expression in Human PC-3 Prostate Cancer Cells

Purpose. To determine whether Ski-interacting protein (SKIP) regulates TGF-β1-stimulated expression of urokinase-type plasminogen activator (uPA), matrix metalloproteinase-9 (MMP-9), and uPA Inhibitor (PAI-1) in the androgen-independent human prostate cancer cell model. Materials and Methods. PC-3 p...

Full description

Saved in:
Bibliographic Details
Main Authors: Victor Villar, Jelena Kocic, Juan F. Santibanez
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Prostate Cancer
Online Access:http://dx.doi.org/10.1155/2013/398253
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556176938631168
author Victor Villar
Jelena Kocic
Juan F. Santibanez
author_facet Victor Villar
Jelena Kocic
Juan F. Santibanez
author_sort Victor Villar
collection DOAJ
description Purpose. To determine whether Ski-interacting protein (SKIP) regulates TGF-β1-stimulated expression of urokinase-type plasminogen activator (uPA), matrix metalloproteinase-9 (MMP-9), and uPA Inhibitor (PAI-1) in the androgen-independent human prostate cancer cell model. Materials and Methods. PC-3 prostate cancer cell line was used. The role of SKIP was evaluated using synthetic small interference RNA (siRNA) compounds. The expression of uPA, MMP-9, and PAI-1 was evaluated by zymography assays, RT-PCR, and promoter transactivation analysis. Results. In PC-3 cells TGF-β1 treatment stimulated uPA, PAI-1, and MMP-9 expressions. The knockdown of SKIP in PC-3 cells enhanced the basal level of uPA, and TGF-β1 treatment inhibited uPA production. Both PAI-1 and MMP-9 production levels were increased in response to TGF-β1. The ectopic expression of SKIP inhibited both TGF-β1-induced uPA and MMP-9 promoter transactivation, while PAI-1 promoter response to the factor was unaffected. Conclusions. SKIP regulates the expression of uPA, PAI-1, and MMP-9 stimulated by TGF-β1 in PC-3 cells. Thus, SKIP is implicated in the regulation of extracellular matrix degradation and can therefore be suggested as a novel therapeutic target in prostate cancer treatment.
format Article
id doaj-art-342afe2e89774a8891ecf6b460f7c70a
institution Kabale University
issn 2090-3111
2090-312X
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Prostate Cancer
spelling doaj-art-342afe2e89774a8891ecf6b460f7c70a2025-02-03T05:46:01ZengWileyProstate Cancer2090-31112090-312X2013-01-01201310.1155/2013/398253398253Skip Regulates TGF-β1-Induced Extracellular Matrix Degrading Proteases Expression in Human PC-3 Prostate Cancer CellsVictor Villar0Jelena Kocic1Juan F. Santibanez2Laboratorio de Biología Celular, Instituto de Nutrición y Tecnología de los Alimentos, Universidad de Chile, 7810000 Santiago, ChileLaboratory for Experimental Haematology and Stem Cells, Institute for Medical Research, University of Belgrade, Dr. Subotica 4, P.O. Box 102, 11129 Belgrade, SerbiaLaboratorio de Biología Celular, Instituto de Nutrición y Tecnología de los Alimentos, Universidad de Chile, 7810000 Santiago, ChilePurpose. To determine whether Ski-interacting protein (SKIP) regulates TGF-β1-stimulated expression of urokinase-type plasminogen activator (uPA), matrix metalloproteinase-9 (MMP-9), and uPA Inhibitor (PAI-1) in the androgen-independent human prostate cancer cell model. Materials and Methods. PC-3 prostate cancer cell line was used. The role of SKIP was evaluated using synthetic small interference RNA (siRNA) compounds. The expression of uPA, MMP-9, and PAI-1 was evaluated by zymography assays, RT-PCR, and promoter transactivation analysis. Results. In PC-3 cells TGF-β1 treatment stimulated uPA, PAI-1, and MMP-9 expressions. The knockdown of SKIP in PC-3 cells enhanced the basal level of uPA, and TGF-β1 treatment inhibited uPA production. Both PAI-1 and MMP-9 production levels were increased in response to TGF-β1. The ectopic expression of SKIP inhibited both TGF-β1-induced uPA and MMP-9 promoter transactivation, while PAI-1 promoter response to the factor was unaffected. Conclusions. SKIP regulates the expression of uPA, PAI-1, and MMP-9 stimulated by TGF-β1 in PC-3 cells. Thus, SKIP is implicated in the regulation of extracellular matrix degradation and can therefore be suggested as a novel therapeutic target in prostate cancer treatment.http://dx.doi.org/10.1155/2013/398253
spellingShingle Victor Villar
Jelena Kocic
Juan F. Santibanez
Skip Regulates TGF-β1-Induced Extracellular Matrix Degrading Proteases Expression in Human PC-3 Prostate Cancer Cells
Prostate Cancer
title Skip Regulates TGF-β1-Induced Extracellular Matrix Degrading Proteases Expression in Human PC-3 Prostate Cancer Cells
title_full Skip Regulates TGF-β1-Induced Extracellular Matrix Degrading Proteases Expression in Human PC-3 Prostate Cancer Cells
title_fullStr Skip Regulates TGF-β1-Induced Extracellular Matrix Degrading Proteases Expression in Human PC-3 Prostate Cancer Cells
title_full_unstemmed Skip Regulates TGF-β1-Induced Extracellular Matrix Degrading Proteases Expression in Human PC-3 Prostate Cancer Cells
title_short Skip Regulates TGF-β1-Induced Extracellular Matrix Degrading Proteases Expression in Human PC-3 Prostate Cancer Cells
title_sort skip regulates tgf β1 induced extracellular matrix degrading proteases expression in human pc 3 prostate cancer cells
url http://dx.doi.org/10.1155/2013/398253
work_keys_str_mv AT victorvillar skipregulatestgfb1inducedextracellularmatrixdegradingproteasesexpressioninhumanpc3prostatecancercells
AT jelenakocic skipregulatestgfb1inducedextracellularmatrixdegradingproteasesexpressioninhumanpc3prostatecancercells
AT juanfsantibanez skipregulatestgfb1inducedextracellularmatrixdegradingproteasesexpressioninhumanpc3prostatecancercells